Actbtm2.1Npa
Targeted Allele Detail
|
|
| Symbol: |
Actbtm2.1Npa |
| Name: |
actin, beta; targeted mutation 2.1, Novartis Pharma AG |
| MGI ID: |
MGI:3769439 |
| Synonyms: |
FRT/Credel |
| Gene: |
Actb Location: Chr5:142888870-142892509 bp, - strand Genetic Position: Chr5, 81.8 cM
|
| Alliance: |
Actbtm2.1Npa page
|
|
| Germline Transmission: |
Earliest citation of germline transmission:
J:129105
|
| Parent Cell Line: |
Not Specified (ES Cell)
|
| Strain of Origin: |
BALB/c
|
|
| Allele Type: |
|
Targeted (Null/knockout, Reporter) |
| Mutation: |
|
Intragenic deletion
|
| |
|
Mutation details: Actbtm2Npa mice were crossed with a cre-deleter strain to remove the floxed stop codon upstream of the EGFP reporter gene. Strong EGFP expression was observed in numerous tissues including brain, heart and kidney.
(J:129105)
|
|
|
| Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
| Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
| Carrying any Actb Mutation: |
51 strains or lines available
|
|
| Original: |
J:129105 Jagle U, et al., Conditional transgene expression mediated by the mouse beta-actin locus. Genesis. 2007 Nov;45(11):659-66 |
| All: |
1 reference(s) |
|
Analysis Tools
